EDAP's MRI (magnetic resonance imaging)-guided HIFU (high intensity focused ultrasound) used for breast cancer:
This article was originally published in Clinica
Executive Summary
French company EDAP TMS has reported that its MRI-guided ultrasound treatment has been used to treat breast cancer for the first time in Europe. Doctors in Germany used the company's MRI-guided high intensity focused ultrasound (HIFU) system to treat the first participant of an 18-patient trial of the product. The system allows doctors to deliver HIFU to a focal point where malignant cells are heated and destroyed. The procedure lasts around three hours, including 80 minutes for the treatment itself. Vaulx-en-Velin-based EDAP already markets its HIFU-based treatment for prostate cancer, Ablatherm, in Europe